BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34687231)

  • 1. Methodological challenges in measuring meaningful change in individuals with spinal muscular atrophy.
    Oskoui M; Potter BK
    Muscle Nerve; 2021 Dec; 64(6):639-640. PubMed ID: 34687231
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical considerations in the study of spinal muscular atrophy. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.
    Buncher CR; Samaha F; Iannaccone ST; Russman BS; Cook JD; White M; McLaughlin C
    Muscle Nerve; 1990; 13 Suppl():S45-8. PubMed ID: 2233886
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).
    Salort-Campana E; Quijano-Roy S
    Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The spectrum of spinal muscular atrophies: a population study].
    Rudenskaia GE; Mamedova RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(8):22-5. PubMed ID: 9343477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infantile spinal muscular atrophy. Description of 2 cases of Werdnig-Hoffmann disease].
    Priora U; Quaglia P; Vivalda M; Giachino-Amistà MT; Domeneghetti G; Sardi R
    Minerva Pediatr; 1987 Sep; 39(17-18):709-14. PubMed ID: 3437861
    [No Abstract]   [Full Text] [Related]  

  • 6. Spinal and bulbar muscular atrophy without tongue atrophy.
    Sugawara M; Kato K; Watanabe S; Toyoshima I
    Eur Neurol; 2001; 45(3):185-6. PubMed ID: 11306865
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial Septal Defect, Neuromuscular Junction and Skeletal Abnormalities in Spinal Muscular Atrophy Type III.
    Luan XH; Liu J
    Chin Med J (Engl); 2017 Oct; 130(19):2382-2383. PubMed ID: 28937047
    [No Abstract]   [Full Text] [Related]  

  • 8. Scoring People With Spinal Muscular Atrophy on the Motor Function Measure Using the Microsoft Kinect.
    Vincent-Genod D; Rippert P; Coton J; Le Goff L; Barriere A; Berruyer A; Bernard M; Garde C; Gutierrez-Garcia M; Gilabert S; Gomes-Lisboade-Souza A; Daron A; Servais L; Thomann G; Vuillerot C
    Pediatr Phys Ther; 2023 Jan; 35(1):36-41. PubMed ID: 36288197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn infant screening for spinal muscular atrophy: Chances and challenges.
    Mueller-Felber W
    Dev Med Child Neurol; 2022 May; 64(5):535. PubMed ID: 35156200
    [No Abstract]   [Full Text] [Related]  

  • 10. Spinal muscular atrophy: some easy clues to diagnosis.
    Gupta PC; Ahuja B; Dhamija K; Mullick DN
    Indian Pediatr; 1989 Oct; 26(10):977-80. PubMed ID: 2630460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It's time to measure disability in spinal muscular atrophy.
    Trabacca A; Ferrante C; De Rinaldis M
    Acta Myol; 2022 Jun; 41(2):57-58. PubMed ID: 35832503
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing perspectives of disease burden and clinically meaningful changes using the Spinal Muscular Atrophy Health Index in adolescents and young adults.
    Mazzella A; Cruz R; Belter L; Curry M; Dilek N; Zizzi C; Heatwole C; Jarecki J
    Muscle Nerve; 2022 Sep; 66(3):276-281. PubMed ID: 35616549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of ECG in the early diagnosis of infantile spinal muscular dystrophy].
    Carboni P; Porro G
    Minerva Pediatr; 1988 Jun; 40(6):321-5. PubMed ID: 3185431
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimal detectable change and minimal clinically important difference in spinal muscular atrophy patients.
    Vázquez-Costa JF; Hervás D
    Eur J Neurol; 2021 Jun; 28(6):e40-e41. PubMed ID: 33604967
    [No Abstract]   [Full Text] [Related]  

  • 15. Spinal Muscular Atrophy Type III Recognized After Delayed Recovery From Neuromuscular Blockade After an Orthognathic Surgery.
    Oda A; Oue K; Yoshida M
    J Craniofac Surg; 2023 Sep; 34(6):e580-e582. PubMed ID: 37253240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuous repetitive task to detect fatigability in spinal muscular atrophy.
    Stam M; Wadman RI; Bartels B; Leeuw M; Westeneng HJ; Wijngaarde CA; van den Berg LH; van der Pol WL
    Orphanet J Rare Dis; 2018 Sep; 13(1):160. PubMed ID: 30208915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbosacral ventral spinal nerve root atrophy identified on MRI in a case of spinal muscular atrophy type II.
    Smith G; Bell SK; Sladky JT; Kang PB; Albayram MS
    Clin Imaging; 2019; 53():134-137. PubMed ID: 30340076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.
    Kirschner J; Butoianu N; Goemans N; Haberlova J; Kostera-Pruszczyk A; Mercuri E; van der Pol WL; Quijano-Roy S; Sejersen T; Tizzano EF; Ziegler A; Servais L; Muntoni F
    Eur J Paediatr Neurol; 2021 Jan; 30():103-104. PubMed ID: 33640649
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal muscular atrophy.
    Wessel HB
    Pediatr Ann; 1989 Jul; 18(7):421-7. PubMed ID: 2666923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.